Valvular & structural heart diseaseCohort study

Atrial Fibrillation and Tricuspid Regurgitation in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair

JACC Cardiovasc IntervPublished

  • Cohort study

Authors' conclusion

Patients with AF, compared with those without AF, experienced greater incidence and progression and less common improvement of TR after M-TEER. In addition, both AF and TR appeared to be independently associated with worse right ventricular status and an increased risk for HF outcomes.

Study context

Population
Patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER)
Participants
1,184 / 229 / 1,423 / 830
Exposure
Atrial fibrillation (AF) and/or significant tricuspid regurgitation (TR) vs no AF and no TR after M-TEER
  • No AF and no TRn = 1,184reference
  • No AF with significant TRn = 229
  • AF and no TRn = 1,423
  • AF with significant TRn = 830
Outcome
CV death or HF hospitalization

Main finding

As reported in the abstract

TR moderate or greater after M-TEER associated with higher adjusted risk of CV death or heart failure (HF) hospitalization, especially with AF

Pinteraction = 0.02

Observational data: associations, not effects.

Further findings

TR prevalence and course by AF

AF associated with higher prevalence of significant TR at baseline, more frequent TR progression and less common improvement during follow-up

Right ventricular remodeling and dysfunction

Both AF and TR appeared independently associated with RV remodeling and dysfunction, with distinct patterns by MR and TR pathologies

Original publication

Atrial Fibrillation and Tricuspid Regurgitation in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair. JACC Cardiovasc Interv. Published 9 January 2026. doi:10.1016/j.jcin.2025.10.041

Summarised from the published abstract; every number is checked against it